Evaluation of two highly effective lipid-lowering therapies in subjects with acute myocardial infarction

Aline Klassen(Universidade Federal de São Paulo), Francisco Antônio Helfenstein Fonseca(Universidade Federal de São Paulo)
Scientific Reports
August 5, 2021
10.1038/s41598-021-95455-z
Cited by 19

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881